All Pathways
General SurgeryEmergency

Acute Cholecystitis Management (TG18 2018)

Acute Cholecystitis Management (TG18 2018): Suspected Acute Cholecystitis → TG18 Diagnostic Criteria Met? → Determine TG18 Severity Grade → Grade I (Mil...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected Acute Cholecystitis

    Patient with RUQ pain, fever, and/or Murphy sign. Consider if: local signs (RUQ pain/tenderness, Murphy sign) + systemic signs (fever, elevated CRP, leukocytosis) + imaging findings

    1. Decision

      TG18 Diagnostic Criteria Met?

      A: Local signs (Murphy sign, RUQ mass/pain/tenderness) + B: Systemic inflammation (fever >38°C, CRP elevated, WBC >10,000/mm³) + C: Imaging findings (US/CT showing gallbladder wall thickening >4mm, pericholecystic fluid, gallstones). Definite: A + B + C. Suspected: A + B

      1. Decision

        Determine TG18 Severity Grade

        Grade I (Mild): No organ dysfunction, mild inflammatory changes. Grade II (Moderate): WBC >18,000/mm³ OR palpable RUQ mass OR duration >72h OR marked local inflammation (gangrenous, pericholecystic abscess, hepatic abscess, biliary peritonitis, emphysematous). Grade III (Severe): Organ dysfunction in any system

        1. Action

          Grade I (Mild)

          No organ dysfunction and mild disease. Local inflammation only.

          1. Decision

            Surgical Risk Assessment

            Assess Charlson Comorbidity Index (CCI) and ASA Physical Status (ASA-PS). Early Lap-C if CCI ≤5 AND ASA-PS ≤2

            1. Action

              Early Laparoscopic Cholecystectomy

              Perform Lap-C as soon as possible, ideally within 72 hours of symptom onset. Early surgery reduces conversion rates, complications, and hospital stay.

              1. Action

                Antibiotic Selection (TG18)

                Community-acquired Grade I-II: Cefazolin or ceftriaxone. Grade II with risk factors or Grade III: Piperacillin-tazobactam, carbapenem, or cephalosporin + metronidazole. Healthcare-associated: Add vancomycin for MRSA coverage. Duration: Until cholecystectomy for uncomplicated; 4-7 days post source control for complicated.

                1. Outcome

                  Cholecystectomy Completed

                  Definitive surgical management achieved. Routine postoperative care. Pathology review for gangrenous/malignancy.

                2. Outcome

                  Drainage + Delayed Surgery

                  Patient stabilized with drainage. Plan interval cholecystectomy in 6-8 weeks. Follow-up imaging to confirm resolution.

            2. Action

              Conservative Management

              IV fluids, bowel rest, IV antibiotics. Consider percutaneous gallbladder drainage if no improvement in 24-48h. Plan delayed Lap-C after inflammation resolves (6-8 weeks).

        2. Action

          Grade II (Moderate)

          Marked local inflammation: WBC >18,000/mm³, palpable mass, duration >72h, or local complications (gangrenous, abscess)

          1. Decision

            Advanced Laparoscopic Skills Available?

            Assess surgical expertise and patient factors. Experienced laparoscopic surgeon at advanced center? Patient CCI and ASA-PS acceptable for surgery?

            1. Action

              Early Lap-C by Expert Surgeon

              Perform Lap-C with experienced surgeon. Higher conversion risk but acceptable. Consider subtotal cholecystectomy if severe inflammation.

            2. Action

              Early Biliary Drainage

              Percutaneous transhepatic gallbladder drainage (PTGBD) or endoscopic approach. Stabilize patient. Plan delayed cholecystectomy once inflammation resolves.

        3. Action

          Grade III (Severe)

          Organ dysfunction present: CV (hypotension requiring vasopressors), Neurological (decreased consciousness), Respiratory (PaO2/FiO2 <300), Renal (oliguria, Cr >2.0), Hepatic (PT-INR >1.5), Hematologic (Plt <100,000)

          1. Action

            Intensive Organ Support

            ICU admission. Aggressive resuscitation: IV fluids, vasopressors if needed, respiratory support. Initiate broad-spectrum antibiotics immediately.

            1. Action

              Urgent Biliary Drainage

              PTGBD is first-line for source control. Endoscopic drainage as alternative. NOT early cholecystectomy - too high risk. Cholecystectomy only after full recovery and optimization.

            2. Warning

              ⚠️ Watch for Gangrenous Cholecystitis

              Signs: persistent fever despite antibiotics, high WBC, gas in gallbladder wall (emphysematous), perforation on imaging. Requires urgent surgery or drainage even if Grade III. Mortality significantly increased if delayed.

Guideline Source

Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address acalculous cholecystitis in detail
  • Pediatric patients require specialized consideration
  • Pregnancy requires modified approach
  • Local surgical expertise influences Grade III management decisions
  • Institutional protocols may vary for biliary drainage techniques

Contraindicated Populations

pediatric

Applicable Regions

USEUGlobal

Global: TG18 is the international standard for acute cholecystitis management

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the Acute Cholecystitis Management (TG18 2018)?

The Acute Cholecystitis Management (TG18 2018) is a emergency clinical algorithm for General Surgery. It provides a structured decision tree to guide clinical decision-making, based on Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis.

What guideline is the Acute Cholecystitis Management (TG18 2018) based on?

This algorithm is based on Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis (DOI: 10.1002/jhbp.516).

What are the limitations of the Acute Cholecystitis Management (TG18 2018)?

Known limitations include: Does not address acalculous cholecystitis in detail; Pediatric patients require specialized consideration; Pregnancy requires modified approach; Local surgical expertise influences Grade III management decisions; Institutional protocols may vary for biliary drainage techniques. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Cholecystitis Management (TG18 2018) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free